Co-Authors
This is a "connection" page, showing publications co-authored by Alessandro Vannucchi and Loredana Poggesi.
Connection Strength
0.505
-
Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia. 2021 04; 35(4):1121-1133.
Score: 0.225
-
The HScore for secondary hemophagocytic lymphohistiocytosis, calculated without a marrow biopsy, is consistently low in patients with COVID-19. Int J Lab Hematol. 2020 12; 42(6):e270-e273.
Score: 0.224
-
Quantitative and qualitative alterations of circulating myeloid cells and plasmacytoid DC in SARS-CoV-2 infection. Immunology. 2020 12; 161(4):345-353.
Score: 0.057